ChemoMetec Past Earnings Performance

Past criteria checks 3/6

ChemoMetec has been growing earnings at an average annual rate of 32%, while the Life Sciences industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 22.8% per year. ChemoMetec's return on equity is 28.8%, and it has net margins of 35.8%.

Key information

32.0%

Earnings growth rate

30.6%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate22.8%
Return on equity28.8%
Net Margin35.8%
Next Earnings Update11 Sep 2024

Recent past performance updates

Recent updates

Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

Apr 15
Some Confidence Is Lacking In ChemoMetec A/S (CPH:CHEMM) As Shares Slide 32%

What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

Mar 01
What ChemoMetec A/S' (CPH:CHEMM) 30% Share Price Gain Is Not Telling You

What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Mar 01
What Does ChemoMetec A/S's (CPH:CHEMM) Share Price Indicate?

Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 08
Earnings Beat: ChemoMetec A/S Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Dec 21
Unpleasant Surprises Could Be In Store For ChemoMetec A/S' (CPH:CHEMM) Shares

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Nov 15
Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Sep 17
ChemoMetec A/S (CPH:CHEMM) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

Sep 15
A Look At The Intrinsic Value Of ChemoMetec A/S (CPH:CHEMM)

At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

Jun 20
At kr.467, Is ChemoMetec A/S (CPH:CHEMM) Worth Looking At Closely?

With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Jun 01
With EPS Growth And More, ChemoMetec (CPH:CHEMM) Makes An Interesting Case

Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

Jan 24
Here's Why ChemoMetec (CPH:CHEMM) Has Caught The Eye Of Investors

If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Oct 26
If EPS Growth Is Important To You, ChemoMetec (CPH:CHEMM) Presents An Opportunity

Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Oct 05
Is It Time To Consider Buying ChemoMetec A/S (CPH:CHEMM)?

Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Jul 18
Does ChemoMetec (CPH:CHEMM) Deserve A Spot On Your Watchlist?

Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Mar 27
Here's Why I Think ChemoMetec (CPH:CHEMM) Is An Interesting Stock

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 12
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Aug 29
Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

Apr 28
Here's Why I Think ChemoMetec (CPH:CHEMM) Might Deserve Your Attention Today

ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 18
ChemoMetec A/S' (CPH:CHEMM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?

Feb 10
ChemoMetec (CPH:CHEMM) Is Growing Earnings But Are They A Good Guide?

What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?

Jan 15
What Type Of Shareholders Make Up ChemoMetec A/S' (CPH:CHEMM) Share Registry?

Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

Dec 20
Do ChemoMetec's (CPH:CHEMM) Earnings Warrant Your Attention?

ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Nov 22
ChemoMetec A/S' (CPH:CHEMM) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?

Revenue & Expenses Breakdown
Beta

How ChemoMetec makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CPSE:CHEMM Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 234021441550
30 Sep 234231611500
30 Jun 234441791440
31 Mar 234531791620
31 Dec 224611801710
30 Sep 224451701660
30 Jun 224281591610
31 Mar 223931451470
31 Dec 213581311330
30 Sep 213201101250
30 Jun 21281881180
31 Mar 21262811080
31 Dec 2024374980
30 Sep 2022967980
30 Jun 2021459970
31 Mar 2020654990
31 Dec 19197481010
30 Sep 1918645980
30 Jun 1917642940
31 Mar 1915837860
31 Dec 1814133780
30 Sep 1812725740
30 Jun 1811318690
31 Mar 1810715690
31 Dec 1710213690
30 Sep 179610660
30 Jun 17907640
31 Mar 17886610
31 Dec 16855590
30 Sep 16858540
30 Jun 168510500
31 Mar 168011470
31 Dec 157512440
30 Sep 156810420
30 Jun 15618410
31 Mar 15565380
31 Dec 14513360
30 Sep 14482350
30 Jun 14451330
31 Mar 14441320
31 Dec 13431310
30 Sep 13421300
30 Jun 13410290

Quality Earnings: CHEMM has high quality earnings.

Growing Profit Margin: CHEMM's current net profit margins (35.8%) are lower than last year (39%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CHEMM's earnings have grown significantly by 32% per year over the past 5 years.

Accelerating Growth: CHEMM's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CHEMM had negative earnings growth (-20%) over the past year, making it difficult to compare to the Life Sciences industry average (6.5%).


Return on Equity

High ROE: CHEMM's Return on Equity (28.8%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.